Covid-19
| Product Name | Product No. | Product Details | Price | Reference |
|---|---|---|---|---|
| HEK-ACE2-GFP cell line | CB-97100-203 | HEK293 was stably transfected with ACE2-GFP expression vector. The cell line has been tested positive for ACE2 antibody staining and GFP signal. It can be used for SARS and SARS-CoV-2 entry study. | $8,000.00 | |
| HEK293-ACE2- Stable cell Line | CB-97100-220 | HEK293 was stably transfected with human ACE2 expression vector. It can be used for SARS and SARS-CoV-2 entry study. | $8,000.00 | |
| pMLV-SARS2-Luciferase pseudovirus particles (614D), 5 ml | CB-97100-146 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $350.00 | |
| pMLV-SARS2-Luciferase pseudovirus particles-614G, 5 ml | CB-97100-146G | $375.00 | A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent | |
| pMLV-SARS2-Luciferase pseudovirus particles-453F (614G), 5 ml | CB-97100-151 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $400.00 | |
| pMLV-SARS2-Luciferase pseudovirus particles-501Y (614G), 5 ml | CB-97100-152 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $400.00 | |
| pMLV-SARS2-Luciferase pp-UK Mutant pseudovirus particles, 5 ml | CB-97100-153 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| pMLV-SARS2-Luciferase pp-SA Mutant pseudovirus particles, 5 ml | CB-97100-154 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| pMLV-SARS2-Luciferase puedovirus particles-222V (614G), 5 ml | CB-97100-155 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $400.00 | |
| pMLV-SARS2-Luciferase pp-Brazil Variant pseudovirus particles, 5 ml | CB-97100-157 | $425.00 | ||
| pMLV-SARS2-Luciferase pp-India Variant pseudovirus particles, 5 ml | CB-97100-160 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| SARS-CoV-2-SA Variant Pseudovirus Particles-b-Lac, 5 ml | CB-97100-154b | $450.00 | ||
| pMLV-SARS2-Luciferase pp-DELTA Variant pseudovirus particles, 5 ml | CB-97100-161 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| pMLV-SARS2-Luciferase pp-Omicron Variant pseudovirus particles, 5 ml | CB-97100-167 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $500.00 | |
| pMLV-SARS2-Luciferase pp-Omicron-BA.2 Variant pseudovirus particles, 5 ml | CB-97100-168 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $500.00 | |
| pMLV-SARS2-Luciferase pp-Deltacron Variant, 5 ml | CB-97100-169 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.4 puedovirus particle, 5 ml | CB-97100-170 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-Luciferase-BA.2.12.1 puedovirus particle, 5 ml | CB-97100-172 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5 puedovirus particle, 5 ml | CB-97100-175 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BF.5 pseudovirus particle, 5 ml | CB-97100-177 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.4.1 pseudovirus particle, 5 ml | CB-97100-178 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.4.6 pseudovirus particle, 5 ml | CB-97100-179 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5.5 pseudovirus particle, 5 ml | CB-97100-180 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BF.3 pseudovirus particle, 5 ml | CB-97100-181 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.2.75 pseudovirus particle, 5 ml | CB-97100-182d | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.2.75.2 pseudovirus particle, 5 ml | CB-97100-183 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BF.7 pseudovirus particle, 5 ml | CB-97100-184 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.4.7 pseudovirus particle, 5 ml | CB-97100-185 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5.9 pseudovirus particle, 5 ml | CB-97100-186 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BJ.1 pseudovirus particle, 5 ml | CB-97100-187 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BQ.1.1 pseudovirus particle, 5 ml | CB-97100-188 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BR.1 pseudovirus particle, 5 ml | CB-97100-189 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5.2.7 pseudovirus particle, 5 ml | CB-97100-190 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5.6.2 pseudovirus particle, 5 ml | CB-97100-191 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBB pseudovirus particle, 5 ml | CB-97100-192 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BQ.1 pseudovirus particle, 5 ml | CB-97100-193 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BN.1 pseudovirus particle, 5 ml | CB-97100-194 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BF7.11 pseudovirus particle, 5 ml | CB-97100-195 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5.2.6 pseudovirus particle, 5 ml | CB-97100-196 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.2.3.20 pseudovirus particle, 5 ml | CB-97100-197 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBC pseudovirus particle, 5 ml | CB-97100-198 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBB.1.5 pseudovirus particle, 5 ml | CB-97100-199P | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BJ.1v2 pseudovirus particle, 5 ml | CB-97100-200 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBF pseudovirus particle, 5 ml | CB-97200-201 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-CA.3.1 pseudovirus particle, 5 ml | CB-97200-202 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-CH.1.1 pseudovirus particle, 5ml | CB-97200-203 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-BA.5.2 pseudovirus particle, 5 ml | CB-97200-204 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-CM.2 pseudovirus particle, 5ml | CB-97200-206 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-Epsilon pseudovirus particle, 5 ml | CB-97200-207 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| pMLV-SARS-CoV-2-Luciferase-Iota pseudovirus particle, 5 ml | CB-97200-208 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| pMLV-SARS-CoV-2-Luciferase-Uganda pseudovirus particle, 5ml | CB-97200-209 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $425.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBB.1.6 pseudovirus particle, 5 ml | CB-97200-210 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBB.2.3 pseudovirus particle, 5ml | CB-97200-211 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-EG.5.1 pseudovirus particle, 5 ml | CB-97200-212 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-XBB.1.16.6 pseudovirus particle, 5 ml | CB-97200-213 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | $525.00 | |
| pMLV-SARS-CoV-2-Luciferase-FL.1.5.1 pseudovirus particle, 5ml | CB-97200-214 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | Coming soon | |
| pMLV-SARS-CoV-2-Luciferase-FBA.2.86 pseudovirus particle, 5ml | CB-97200-215 | For screening inhibitors to block SARS-CoV-2 infection; Validating neutralization antibodies. | Coming soon |